Background: Mouse embryonic stem (ES) cells remain pluripotent in vitro when grown in the presence of the cytokine Leukaemia Inhibitory Factor (LIF). Identification of LIF targets and of genes regulating the transition between pluripotent and early differentiated cells is a critical step for understanding the control of ES cell pluripotency.
responses. We are also reporting on the identification of genes whose expression is strictly regulated during the commitment step. Furthermore, our studies identify sub-networks of genes with a restricted expression in pluripotent ES cells, whose down regulation occurs while the master knot (composed of OCT4, SOX2 and NANOG) is still expressed and which might be downregulated together for driving cells towards differentiation.
Background
Mouse embryonic stem cells (ES), which are derived from the inner cell mass of blastocysts, are valuable for studying pluripotency. Indeed, these cells recapitulate the complete mouse developmental program when injected into fertilized eggs and are widely used to introduce targeted mutations in mice [1, 2] . In addition, they can be induced to differentiate in vitro to various cell types of the three germ layers and are therefore of great interest for study signalling pathways leading to specialized cell differentiation [3] [4] [5] . Knowledge of molecular determinants that regulate stem cell fate and understanding their functions are key challenges for future therapy based on stem cells in which their plasticity has to be properly controlled.
Two major pathways have been characterized so far, leading to the identification of "master genes" critical for the maintenance of mouse ES cell pluripotency: the LIF/ STAT3 pathway, which synergizes with BMP2/4 and/or Wnt family members (as Wnt3a, Wnt5a and Wnt6, [6] [7] [8] ), to maintain ES cell pluripotency alone [9] [10] [11] [12] [13] [14] , and the OCT4/SOX2 and NANOG pathways, the last one identified in cells in which the LIF pathway has been knockeddown [15] [16] [17] [18] [19] [20] . The many known regulators of ES cell pluripotency, like c-yes, [21] , c-myc, [22] , foxd3 [20] and those characterized by gene profiling studies [23] [24] [25] [26] might be classified in one or the other pathway. However, the exhaustive characterisation of transcriptional targets of LIF in ES cells and in their early differentiated derivatives has not been reported and the specificity of LIF targets versus those of OCT4 or NANOG has not yet been investigated [27] [28] [29] .
LIF is a member of the Interleukin-6 (IL-6) family of cytokines, which displays pleiotropic functions, depending on both cell maturity and cell type [30] [31] [32] . Indeed, while LIF maintains ES cell pluripotency and is a critical cell survival factor in myocytes, embryonic germ cells, particular subtypes of neurons and osteoblasts, it induces differentiation of the M1 leukemic myeloid cell line, can switch the identity of neurons [33] , induces cell cycle arrest in cancer cells [34] and has a key pro-apoptotic role during the post-gestation process of mammary gland involution [35] [36] [37] .
In mouse ES cells, LIF induces signalling pathways including JAK1/STAT3/MYC/CD9/SOCS3/PI3K and ERK/RSK/ CREB leading to activation of both anti-and pro-differentiative signals [23, [38] [39] [40] [41] [42] [43] [44] . The transcriptional targets of LIF are the outcomes of these signalling cascades and their identification is a critical step for understanding the control of ES cell pluripotency. Also, LIF-dependent gene profiling performed in various cell states (pluripotent, reversible and irreversible commitment), should help to define different groups of LIF responsive genes, leading to a better understanding of pleiotropic effects of this cytokine.
The aim of this study was to characterize the LIF transcriptome of mouse ES cells as well as to identify novel regulators of the transition from pluripotent to irreversibly committed cells. By gene profiling studies, performed on ES cells cultured under various conditions, we have identified eight independent gene clusters including a novel gene category whose expression level varies transiently in reversibly committed cells only. Moreover, our strategy allowed us to identify different sets of LIF-regulated genes and to define those ones also regulated by OCT4 or NANOG. The effects of selected genes on ES cell differentiation were also investigated.
Results

1) -LIF targets in mouse ES cells: experimental design
To identify LIF targets in pluripotent and committedderived ES cells as well as key genes regulated during the transition from pluripotent to early differentiated cells, we carried out an experimental strategy based on these three facts i) A complete change of cell culture medium (including serum and LIF) is required every 48 h to induce a boost in STAT3 phosphorylation allowing cells to remain pluripotent, ii) 24 h after LIF withdrawal, STAT3 is inactivated by dephosphorylation and if incubated for longer in the absence of LIF, ES cells will differentiate. However, if LIF is added back 24 h after its withdrawal, differentiation is prevented and cells maintain their pluripotent state. Cells generated following 24 h of LIF starvation can therefore be categorised as in a state of reversible commitment, iii) 48 h following LIF withdrawal, while remaining LIFsensitive, cells are irreversibly committed to differentiate. Indeed, even if LIF is added back, cells differentiate and a proportion of them die by apoptosis [24, 38, [45] [46] [47] . The LIF-dependent kinetic experiments of STAT3 activation showed a maximal stimulation at 30 min., which corresponds to the maximal level of phospho-tyr705 and phos-
The experimental strategy Figure 1 The experimental strategy. A1) Western blot analyses showing STAT3 and P-STAT3 and A2) band shift analyses of specific LIF-dependent complexes in ES cells depleted of LIF for 24 h and reinduced with LIF for 10 to 120 min. or in pluripotent cells (+ LIF) as indicated. LIF specific complexe containing STAT3 (arrow) and non specific complexe (asterisk) are indicated. (-) or treated for 25 min with FBS or FBS and LIF as in B). Western blot analysis were performed with antibodies reacting against all forms of STAT3 (STAT3), the activated STAT3 (P-STAT3 Tyr705) or with OCT4 and ERK2. D) Semi-quantitative RT-PCR performed with total RNAs from ES cells grown as indicated in B), have been performed with primers corresponding to the indicated genes.
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Rev. pho-ser727 STAT3 protein leading to the formation of active STAT3-DNA complexes ( Figure 1A ).
Gene profiling experiments were carried out with mRNA extracted from the CGR8 mouse ES cell line cultured under growth conditions as defined in Figure 1B . Cells in Pluripotent (Pluri), reversible (Rev.) or irreversible (Irrev.) commitment states were treated with serum or serum and LIF, 25 min. before harvesting. Protein lysates were also prepared in parallel with RNA samples. Analysis of LIF-dependent induction of STAT3, as detected by the extent of its phosphorylation, confirmed LIF responsiveness of pluripotent, reversibly, and irreversibly committed cells. In addition, we observed a progressive decrease in the levels of STAT3 protein after 24 h and 48 h of LIF starvation, which correlates with the loss of cell pluripotency. In contrast, no changes in OCT4 protein level was observed at these early times of cell differentiation. As expected, the amount of ERK2 proteins was unaltered under these various conditions and therefore, it was used as a protein loading control ( Figure 1C ). The quality of mRNA hybridized to microarrays was checked by RT-PCR experiments on a control (Hprt) and known LIF-induced genes as Socs3, JunB and Fos and the pluripotent Klf4 gene, [23, 48] , ( Figure 1D ).
2) Gene expression profiling in the absence or presence of LIF
Five independent total RNA preparations from each condition, ( Figure 1B) , were processed and hybridized on the Mouse Genome 430 2.0 Array (Affymetrix) which includes 45101 probe sets. After RMA normalisation [49] and outlier removal, pairwise comparisons have been performed using the paired Student t-test (summarized in Figure 2 ). This allows the classification of genes into 7 tables (Tables 1 to 7 , see Additional file 1). In addition, multiple testing correction has been performed using the Benjamini and Hochberg procedure [50, 51] , as described in the Methods section. Tables 1 and 2 show the sets of the LIF-regulated genes detected in ES cells reversibly and irreversibly committed to differentiate following acute treatment with LIF. Genes whose expression was induced by LIF, named hereafter Lifind genes, belong to various gene families including the Early growth response genes (Egr1,2), members of Immediate early response (Ier2 and 3), and of Kruppel-related gene (Klf4 and 5) families, Ras-dex1, Ypel2 and the PI3K regulator Dapp1. In addition, an EST of unknown function, 1459961_at, encoded by a gene localized at proximity of the Stat3 locus (5' to the promoter) has also been retrieved (named Stat3Loc, see Additional file 2). A subgroup of genes induced after 24 h of LIF withdrawal was also induced after a 48 h period of LIF starvation (compare Tables 1 and 2 ). In addition, few LIF-repressed genes (Lifrep genes), with the extent of repression less than 2fold, were retrieved 24 h after LIF withdrawal (Ddh2, Mtss1, Chd8 and ESTs), and no repressed genes were identified after 48 h of LIF starvation. While our stringent criteria of gene selection by the t-test analyses do not lead to the identification of LIF-modulated genes in pluripotent cells (+ LIF conditions), we detected a LIF-dependent increased expression of some genes, including Ypel2, Plscr1, Dapp1, JunB, Stat3Loc and Klf5, in pluripotent cells, by semi-quantitative RT-PCR analysis (see below, Figure  4 ). Altogether, these results showed that the LIF response was different in pluripotent, reversibly and irreversibly committed cell populations, suggesting that LIF outcomes do not rely on the sole activation of STAT3, similarily induced in these three conditions. Tables 3 and 4 depict pair-wise comparisons of genes whose expression was significantly diminished after 24 h ( Tables 5, 6 and 7 gather genes whose expression increases upon LIF withdrawal. Twenty genes, whose expression level was up regulated in irreversibly committed cells versus pluripotent cells, were also expressed in reversibly committed cells (genes quoted as "YES" in Table 5 , like Lef1, Wt1, Dnmt3a and b, Oct6 and Otx2). This findings suggest that irreversible commitment maybe linked to the sustained expression of a set of genes expressed at earlier time following LIF withdrawal. In table 5, we noted that the majority of genes (120 out of 140) has a particular expression profile characterized by low level of expression in pluripotent cells, high level of expression in reversibly committed cells and low level of expression again in irreversibly committed cells ("low-high-low" profile, quoted as "NO", in Table 5 ). These genes, including Bhc80, Bicd1, Six4, Bmi1, Aire, Jmjd1c, Jmjd2c and Tle4, define a new cat-egory of genes, whose expression is transiently induced in reversibly committed cells (see also below, in Figure 3 ). Table 7 includes genes induced at 48 h versus 24 h of LIF starvation. Some of these genes are specific of the irreversibly committed cells.
3) Gene clustering of all conditions
We performed an ANOVA (F-test) on data obtained under the different cell growth conditions. The expression profiles of highly significant differentially expressed genes [pvalue < 10 -6 with a FDR (False Discovery Rate) of 1.48. 10 -4 ; n = 292] have been categorized using hierarchical clustering. This allowed to group genes with similar expression profiles, an indication of potential co-regula-tion and common functions [52] . Tree view representation of the clusters led to the identification of eight independent groups of genes ( Figure 3 ). The upper dendrogram shows the expected clustering of the different cell growth conditions with the pluripotent state in one branch (pluri.), and the reversibly (r. com.) and irreversibly (ir. com.) committed conditions in the other branch. The complete list of genes of the cluster analysis is available (see Additional file 3).
Cluster 1 (similarity score = 0.7547) includes genes whose expression, induced at 24 h of LIF starvation, is sustained at 48 h (Foxp1, Enpp3, Otx2, Pak1, Wt1, Gja1, Lef1 and Pluri. 
Identification of eight independent gene clusters
differentiated markers specific of the irreversibly committed cells, like Car4, Embigin, Fgf5, Ptpn13, Irx3, Fgfr11, Rbp7, some of them corresponding to known cell lineage markers such as Fgf5.
Clusters 2 (similarity score = 0.7938) and 7 (similarity score = 0.7109), are the mirror image from each other and define new atypical gene behaviors. Modulation in the expression level of these genes was only detected in the reversibly committed cell population. Indeed, the expression profile of these genes is: "high-low-high" (Cluster 2) or "low-high-low" (Cluster 7) in "pluri -r.com -ir.com" cell growth conditions. Among genes from Cluster 2 we identified Vimentin, Hspb8 and Jund2. Genes from Cluster 7 include transcription factors like Mlr2, Aire, Tle4 and chromatin regulators as Bhc80, Smarca2. Genes from these clusters might be necessary to regulate the transition from pluripotent to irreversibly committed cells and their identification would not have been possible without the clustering of all data obtained in our experimental conditions. Clusters 4 (similarity score = 0.8109), 5 (similarity score = 0.8170) and 6 (similarity score = 0.7163) define genes highly expressed in pluripotent cells and whose expression level, was i) abruptly decreased 24 h following LIF starvation (in Cluster 5: Pim3, Fzd5, Sod2, Esrrb, Tcfcp2l1, Mras, Gjb3 and 5, Bcl3, Stat3, Smarcd3, Yes and Cd9), ii) progressively decreased, (in Cluster 4: Stmn1 and 2, Scarb2, Timp1, Pcolce, Tcl1 and Trps1) or iii) decreased only 48 h after LIF starvation (in Cluster 6: Lgals3, Cordon bleu, Vegfc, Zfp74, Hist1h1c). Genes from cluster 5 are named "Pluri" genes thereafter.
Cluster 8 (similarity score = 0.7488) includes genes whose expression was induced by LIF in both reversibly or irreversibly committed cells. Only one gene (probe set 1446583_at) was found repressed by LIF in this analysis.
The regulated expression of a selection of genes from each cluster and Tables 1 and 2 (see Additional file 1) was validated by semi-quantitative RT-PCR ( Figures 3B, 4A and 4B).
4) Cell fate-independent and cell-specific Lifind genes
To determine whether the Lifind genes from Table 1 (see Additional file 1) are modulated by LIF in other cellular context, we analysed their expression profile with the heatmapper tool, under our set of conditions ( Figure 5A ), and in an embryoid body (EB) kinetic analysis following LIF withdrawal, from day 1 to day 10 ( Figure 5B ). Indeed, we had previously shown that some LIF targets (like Socs3, Fos and JunB) are expressed, several days after LIF withdrawal, in differentiated cells [46] . In this study, we extended this analysis and showed that almost all the genes induced by LIF in reversibly and irreversibly com-mitted cells, are re-expressed, concomitantly with the reexpression of LIF and of its receptors (gp130 and gp190) at day 10 of EB differentiation (Figures 5B and 5C). In contrast, genes marked with an asterisk in Figure 5A are not re-expressed (see Figure 5B ). Therefore, we have characterized two types of Lifind genes: those induced by LIF at 24, 48 h and 10 days after LIF withdrawal and which correspond to cell fate-independant LIF targets [named hereafter "Pleio-Lifind" genes and including Socs3, Fos and JunB] and genes whose induction by LIF is cell-restricted [named hereafter "Spe-Lifind"genes] and which were not known, so far, as LIF targets.
5) Regulation of "Pluri" genes in embryoid bodies kinetic following LIF withdrawal
Genes from Cluster 5 (represented in Figure 6A ), were also analysed with the heatmapper tool in the time course of EB differentiation ( Figure 6B ). Master genes, Oct4, Sox2 and Nanog, whose expression is stable up to day 2 (Sox2) or day 3 (Oct4 and Nanog) and which are therefore not present in cluster 5, were manually added for this analysis. Three groups of genes were identified: i) those strictly expressed in pluripotent cells (red line, Cluster a), including pluripotent cell marker like Esrrb; ii) those reexpressed at day 10 of the EB diffentiation kinetic (blue line, Cluster b), including the LIF-dependent Cd9 gene [39] , and iii) genes whose expression was higher in differentiated than in pluripotent cells (blue line, Cluster c), including Stat3. This analysis helps to identify relevant new genes potentially involved in the maintenance of ES cell pluripotency, since known pluripotent markers are present in each of these clusters.
6) Analyses of Lifind and Pluri gene expression in Oct4 and Nanog knock-down experiments
The overall expression level of Oct4 and Nanog was unaltered up to three days upon LIF withdrawal in the kinetic of embryoid bodies ( Figure 6B ). However, the recent finding that ES cells are heterogeneous for the expression of many markers, like NANOG but no OCT4, prompted us to determine whether the expression level of genes identified in this study could be directly modulated by these master genes. This should help to find a specificity of these core "pluripotent master genes" [53, 54] . We have analysed expression profiles of Lifind and Pluri genes after knock-down of Nanog and Oct4 by RNAi. Availability of Affymetrix data, from Loh et al, [19] , performed with mouse ES cells infected with lentivirus expressing shNanog or shOct4 silencing RNAs, allowed such an analysis. Heatmapper analyses were performed with Lifind ( Figure 7A ) or Pluri genes ( Figure 7B ). The expression of Lifind genes are either repressed like Ier2, Socs3, klf5 or Egr1 ( Figure 7A , Cluster 1) or induced like Zfp36, Fos and Rasd1 ( Figure 7A , Cluster 2) by Oct4 knock down. Remarkably, Ier3 is the only Lifind gene whose expression is repressed by Nanog silencing. In addition, this analysis emphasizes the particularity of some Spe-Lifind genes (like Pabpc1, Plscr1, Dapp1 and Dyst) and of JunB, Sbno2 and Egr2 whose expression is altered neither by Oct4 nor by Nanog silencing.
A similar analysis has also been conducted with the Pluri genes ( Figure 7B ), highlighting their differential regulation by Oct4 or Nanog. Indeed, we identified 5 groups of genes whose expression is down (like Sox2, Irak3 and Susd2 in Figure 7B 
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Ier2 (Tables 1 and 2) Hprt Cluster 3). These analyses define novel gene categories, not similarly regulated by master genes, which might be part of novel sub-networks involved in the regulation of ES cell pluripotency.
7) Effects of knock-down of a selection of Lifind and Pluri genes in pluripotent cells
In silico analyses allowed us to select genes among the Lifind and Pluri genes for further functional studies. We focused our efforts on a selection of Spe-Lifind genes (Dapp1, Plscr1, Dyst, Pabpc1) and also included Ier3 owing to its particular expression profile in Oct4 and Nanog silencing experiments. Concerning the Pluri genes, we performed the experiments with genes specifically expressed in pluripotent cells such as Irak3, Susd2 and Ly6 and whose expression was affected by only one master gene (Oct4), except Ly6, which behaves as Esrrb, a recently identified pluripotent marker [25, 55, 56] . We have also included Tcfcp2l1, a transcription factor strictly expressed in pluripotent cells ( Figure 6B , Cluster a).
We have tested the function of these genes using an RNA interference strategy. Endoribonuclease prepared (e) siR-NAs [57] were generated, targeting the different genes. ES cells were transfected twice with each esiRNA and stained with Alkaline phosphatase (ALP) five days after the first transfection (see Additional file 4). Knock-down of Stat3 and Oct4 led to morphological cell differentiation (with loss of ALP staining), and proliferative defects similar to that observed when LIF was withdrawn for 4 to 5 days, consistent with their known function in maintaining pluripotency (positive controls). Knock-down of the various genes tested did not induce significant morphological changes, as shown for Ier3 as well as for the other genes 
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Days of differentiation Days of differentiation Days of differentiation ure 3) occurred much earlier than morphological changes, which are observed at three days upon LIF withdrawal (see Additional file 4A) and as reported in other ES cell lines, [47, 58] . This prompted us to analyse the effects of gene silencing on the expression of early differentiation markers. Expression level of Lef1, Pak1, Car4 and Dnmt3a, all induced at 24 or 48 h of LIF withdrawal (see Figure 3 ), was analysed after 5 days of transfection in ES cells grown with LIF. The expression of Nestin, Gata4, Gata6 and Sox17, induced at later times of LIF withdrawal, was also studied. The efficiency of the silencing of each esiRNA was determined by RT-qPCR and shown to be in the range of 50 to 80% (see Additional file 5 and not shown). The expression of almost all the differentiation markers tested was modulated by the silencing of Stat3 or Oct4. However, individual silencing of the selection of Lifind or Pluri genes led to no effects or modest up regulation of some of the tested differentiation markers (see Additional file 5).
Discussion
From pluripotent to irreversibly committed cells: The LIF impact
By gene profiling studies performed with pluripotent murine ES cells and with reversibly or irreversibly ESderived committed cells, treated or not with LIF, we end up with a new global view of the genetic program leading from pluripotent to differentiated cells, as summarized in Figure 8 : When LIF is withdrawn for 24 h, cells enter the commitment phase and the expression of 59 genes declines (like Bcl3, Klf4, Stat3, Yes, Esrrb, Nanog, M-ras, Fzd5), while the expression of 140 genes increases (like Lef1, Otx2, Wt1, Dnmt3a, b and Fzd7). When LIF is added In silico analysis of Pluri genes Figure 6 In silico analysis of Pluri genes. Heatmapper analysis of genes from Cluster 5 (as defined in Figure 3 and represented here in panel A) has been performed with Affymetrix data taken from the kinetic of LIF withdrawal (d1 to d10 of EBs differentiation), B) Relevant clusters are highlighted by red (a) or blue lines (b and c). The asterisk points to three master genes, sox2, oct4 and nanog manually included in this analysis. Otx2 was recently shown to be a critical regulator of early cell differentiation [25] . LIF treatment of cells starved of LIF for 48 h does not reset the stemness program as shown by their inefficiency to form teratomas or colonize blastocysts [45, 59] . Our statistical study reveals differences in the set of LIF targets induced after a 24 h or a 48 h period of LIF starvation. Indeed, only a portion of the genes identified in reversibly committed cells was induced by LIF in irreversibly committed cell population. In addition, the extent of LIF induction was less than half that observed in reversibly committed cells, despite the fact that STAT3 phosphorylation and activity remained very high in both situations. This suggests that activated STAT3 could regulate a cell-state-dependent pathway which locks cells in a differentiated state.
Three LIF-dependent signatures
Our analysis has allowed also to distinguish between Spe-Lifind (genes induced by LIF in a restricted cellular context), Pleio-Lifind (genes induced by LIF in various cellular context and potentially involved in pleiotropic effects of LIF) and Pluri genes. This last category corresponds to LIFdependent genes, not reinducible by LIF in the first 48 h
In silico analysis of Lifind and Pluri genes: Regulation by OCT4 or NANOG Figure 7 In silico analysis of Lifind and Pluri genes: Regulation by OCT4 or NANOG. Heatmapper analyses performed respectively with LifindA) and PluriB) genes whose level of expression was analysed in microarray experiments taken from Loh et al, [19] . Relevant clusters are marked with black lines and numbered. Color code is like in Figure 3 . yellow: expression above the median; black: median expression; blue: expression below the median. of differentiation (summary in Figure 8 ). Some of the Pleio-Lifind genes are known for their impact on stemness, [like Klf4 or Socs3 [23, 41, 48] ], in trophoblast differentiation (like Socs3, [60] ) and for their activation in the M1 myeloid cell line, in which LIF is pro-differentiative (like JunB and Egr1 [61] [62] [63] ). However, none of the Spe-Lifind genes has previously been identified as LIF targets. Many of these genes are not well characterized, and their potential responsiveness to LIF could help unravelling their function. In addition, the comparison of LIF regulated genes identified in our study with those reported in microarray analyses, performed on other cell types or tissue [cardiomyocytes [64] , neurons [65] and uterus [66] ], shows no overlap except stat3 (summary in Figure 9 ). However, both the different timing of LIF induction (25 min. in our study versus several hours in these other studies) and cell context, [48, 67, 68] , might account for this absence of overlap. Our screen reveals also a partial overlap between LIF targets identified in this study, and STAT3 targets, previously reported [47, 69] suggesting that LIF and STAT3 pathways might have various outcomes which are not yet fully identified, and that LIF-dependent response might not be under the sole control of STAT3.
Our screen revealed that there are few LIF-repressed genes. This emphasizes the point that LIF effects are regulated through the synthesis of repressors (e.g., Socs3). Mereover, new LIF-induced negative regulators might be critical for maintenance of cell pluripotency. Such a candidate could be Zfp36, which encodes for a protein involved in mRNA stabilization through the ARE (Au Rich Element) sequence [70, 71] . We found that a proper level of this protein was necessary to ensure survival of pluripotent cells since its overexpression led to cell death (our unpublished results). Along with the recent finding that ZFP36 regulates directly the stability of Ier3 mRNA [72] , a new Lifind Highlights of microarray analyses performed in pluripotent, reversibly and irreversibly ES-derived committed cells, treated or not with LIF Figure 8 Highlights of microarray analyses performed in pluripotent, reversibly and irreversibly ES-derived committed cells, treated or not with LIF. A selection of genes regulated in each cell state is presented. Bolded genes are the pleio-Lifind genes, identified in the ES cell system or in other LIF sensitive cell types. gene identified in that study, it is tempting to propose that differential stabilisation of mRNAs could have an impact on the survival of pluripotent ES cells.
Lifind genes regulation by OCT4 or NANOG
We have classified Lifind genes into different sub-groups depending on their differential regulation by Oct4 or Nanog (summary in Figure 10 ). Expression of almost none of the Spe-Lifind genes is modulated by the silencing of these two master genes, emphasizing their belonging to a LIF specific pathway [18, 20, 73] . However, the individual knock-down of four of these genes (Dapp1, Plscr1, Dst and Pabpc1) does not lead to morphological changes nor to a significant alteration in the expression of a selection of early differentiation markers. Disruption of all four genes together might be required before any effect becomes apparent. Alternatively, these genes could be involved in the reversibility of committed cells grown without LIF for 24 h, [38, 74] , a potentiality not tested in the present study.
Novel characteristics of Pluri genes and differential regulation by OCT4 or NANOG
The Pluri genes retrieved in this analysis include genes previously shown to maintain cell pluripotency like Yes, Cd9, Esrrb, Tcl1 and Tbx3 [21, 25, 33, 39] ) and many novel genes (summary in Figure 8 ). We show that Pluri genes could be endowed with new features, which might be relevant to explain cell fates. Indeed, while expression of known master genes (Oct4, Sox2 and Nanog) is maintained for 2 or 3 days following LIF withdrawal, expression of almost all the genes identified in our analysis ( Figure 3A , Cluster 5) is decreased on the first day of LIF withdrawal like Esrrb or Pim3, recently identified as new pluripotent genes [25, 75] . The direct targets of Esrrb and Tcfcp2l1 (both in Cluster 5) were recently characterized, allowing the identification of novel regulatory complexes and stressing the potential importance of sub-networks to regulate cell pluripotency [55] . Also, some of these genes are reexpressed 10 days after LIF withdrawal, therefore becoming LIF responsive in these differentiated cells. In addition, the silencing of Oct4 or Nanog decreases the expression of many of these genes together, potentially explaining why the individual knock-down of some of these Pluri genes does not affect cell pluripotency.
We have identified genes whose expression depends of Oct4 only (like Irak3, Susd2) or of both Oct4 and Nanog (like Esrrb, Fzd5, Ly6 or Sod2) or of none of them. Genes whose expression is induced by Oct4 (including Gjb3, Gjb5 and Cd9) or Nanog silencing (Ceacam1), have also been identified (data summarized in Figure 10 ). However, for unknown reasons, these genes were almost not expressed in pluripotent cells used in the study of Loh et al., [19] while highly expressed in the CGR8 cells used in our study and could be among genes whose expression fluctuates between various types of ES cells, as already described [76] .
A) Compilation of a selection of microarray data and comparison with our results
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h without LIF: a critical window for cell fate choices
In this study, we also demonstrated that upon LIF withdrawal, cells go through a transition phase in which the expression of a new set of genes is modulated. Hierarchical clustering analysis was of fundamental importance for the characterization of two types of gene clusters, which displayed "high-low-high" (Figure 3A, cluster 2) or "lowhigh-low" (Figure 3A, cluster 7) expression levels in the three cell fates analysed "pluripotent, reversibly and irreversibly committed". Some of these genes, (Table 5 , see additional file 1), from the Jumonji family, encoding for specific Histone demethylase, have recently been reported as being essential for the maintenance of ES cell pluripotency [77] . In addition, among genes from cluster 7, transcription factors (Tcfec, Zfp532) and chromatin regulators (Bhc80, Smarca2 and Tle4) might be critical for the regulation of the expression of genes of cluster 2 (Mapk13, Hspb8, Vim and Jundm2) [78] . The functional role of these new gene clusters, to drive the transition from pluripotency to irreversible differentiation, will be a future goal.
Conclusion
Our work has provided a novel global view of LIF reponses in mES cells and in their early-derived derivatives and allowed the identification of various sets of LIF-Lifind and Pluri gene expression in ES cells in which the expression of Oct4 or Nanog has been knocked-down Figure 10 Lifind and Pluri gene expression in ES cells in which the expression of Oct4 or Nanog has been knocked-down. Summary of Pleio-and Spe-Lifind gene regulation A), and of Pluri gene regulation B), by Oct4 and/or Nanog, based on the heatmapper analysis.
induced (Lifind) and Pluripotency (Pluri) genes. We have also characterized sub-networks of genes whose expression is modulated while the master knot (composed of OCT4, SOX2 and NANOG) is still expressed, and which are partly under Oct4 and/or Nanog control. Furthermore, our study has led to the identification of gene clusters with atypical expression profiles, which desserve to be studied in details for their potential function in ES cell physiology. The recent demonstration that mouse ES cells are heterogeneous for the expression of different genes, like Rex1 [79] , Nanog [53] and many others characterized by in situ hybridization [54] , along with the identification of new genes from this study, open new roads for understanding and controlling ES cell plasticity. [49] ). After outlier removal using the Nalimov test at p < 0.001, a parametric ANOVA (F-test) has been applied to get global expression differences between the six different conditions. Multiple testing correction has been performed using the Benjamini-Hochberg procedure [50] . Hierarchical clustering of expression values of probe sets highly significant, differentially expressed in the ANOVA (n = 292; pvalue < 10 -6 and FDR < 1,48. 10 -4 ) was performed by using Cluster version 2.11 [52] applying mean-centering and normalization of genes and arrays before average linkage clustering with uncentered correlation. To detect distinct expression differences between the growth conditions, paired Student t-tests of transcripts differentially expressed in ANOVA (FDR < 0,05) have been applied. Student t-test p-values and fold changes between the conditions, averages and standard deviations for each condition have been documented.
Methods
Cell culture, treatments for microarrays and reagents
Heatmapper analysis
Heatmapper tool allows a graphical representation of the level of expression of many selected genes across a number of samples from various experimental conditions, as they have been obtained with similar DNA microarrays (eg: A430 2.0) [82] . The mean "signal" value from 3 independent experiments obtained from Affymetrix DNA analysis [(arrays A430 2.0: d0 to d10 of LIF withdrawal kinetic on embryoid bodies, (Sachinidis, A. et al, unpublished results)] have been compared with our current data analysis results. A Web-based tool that allows i) quick browsing of user-provided gene sets, ii) standard hierarchical clustering [52] and iii) heatmap-visualisation across multiple data sets, has been created and used for performing this study. This data analysis environment is currently being developped further into a systematic mouse stem cell data analysis atlas (R. Kolde and J. Vilo, unpublished results). Similarly, samples from Affymetrix data of Loh et al, [19] , available at GEO data base under the access number: GSE4189, have been added in the interface created, as a way to perform analyses as shown in Figure 7 .
Cell lysates, Western blots and Band Shift experiments
Plated cells were rinced twice with room temperature PBS and lysed directly in mild RIPA buffer (PBS, 1% triton, 1% NP40, 0.05% SDS, 1 μg/ml protease inhibitor cocktail, 1 mM Pefabloc, 20 mM NaF, 1 mM Na vanadate) and centrifuged 10 min at 10000 rpm. Cell lysates were resolved by SDS-PAGE and electro-transferred onto nitrocellulose membranes. Proteins were reacted with the different antibodies, as recommended by the manufacturers. Band shift experiments have been performed with nuclear cell lysates as described [38] , with the SIE DNA probe, a high affinity DNA binding site for STAT3. Band shifs were performed in the presence of a 100× molar excess of unlabelled wild type (wt) or mutated (m) competitor oligonucleotides encompassing the SIE sequence.
Semi-quantitative RT-PCR and RT-qPCR
Total RNAs from adherent ES cells were prepared with the Qiagen column kit (Qiagen) and treated with DNAse (5 U/100 μg RNA, Sigma). Total RNAs (5 μg) were reversetranscribed (RT) with random hexameric primers and the MLV Reverse Transcriptase (Sigma). The RT reaction products were used for PCR with specific primer sets as described [48] . Sequences of primers used for all the genes tested in semi-quantitative RT-PCR (shown in Figure 3 ) are in Additional file 6.
Quantification, of the extend of Knock-down and of the expression of differentiation markers (see Additional file 5), was performed by RT-qPCR with the MX4000 system (Stratagene) as previously described [83] . The relative expression of the genes of interest was deduced of the Ct using the ΔΔCt method with Hprt house-keeping gene as the reference. Sequences of primers used in RTq-PCR are in Additional file 7.
The validation of the expression of LIF cytokine and of its receptors by RT-qPCR analysis (shown in Figure 5C ) was performed with the ABI Prism 7500 Fast System (Applied Biosystems, Foster City, CA). 1 μg total mRNAs of ES cells and of EBs, obtained from 3 independent experiments (biological triplicates), were reverse transcribed with Ther-moScript™ Reverse Transcriptase (Invitrogen, Karlsruhe, Germany). Then real-time PCR was performed with technical triplicates for every sample using TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA). The Gene Expression Assays used were Lif (Mm00434761_m1), Lif receptor (gp190) (Mm00442940_m1), Interleukin 6 signal transducer (gp130) (Mm00439668_m1) and Gapdh (Mm99999915_g1). C t values of each qPCR reaction from the target gene were normalized with the respective C t values of the housekeeping gene, Gapdh, that ran in the same reaction plate to obtain the Δ C t value. The fold change was calculated as follows: fold change = 2 -(ΔCt gene1 -ΔCt gene2) . The ΔC t of the gene in the sample with the lowest expression is used as ΔCt gene2 to calculate the fold change using the above formula. The resulting fold change is expressed as mean ± SD.
RNAi experiments
Endoribonuclease-prepared short interfering RNA (esiRNA) was synthesized according to the protocol described in [57] . Briefly, selected transcripts were analysed with the software program Deqor [84] to identify the best region for esiRNA synthesis. Primers with appending T7-RNA polymerase-tags were designed and used to amplify gene specific PCR products of about 500 bp in length. These fragments were used to generate dsRNA that was subsequently digested to esiRNAs with E. coli RNaseIII. The esiRNA was purified and used to transfect ES cells using Lipofectamine 2000. ES cells were plated in complete medium without antibiotics, on gelatinized 24-wells dishes at day 0, to achieve 60-70% confluency on the day of transfection (day 1). 150 ng of esiRNA (diluted in qsp 50 μl of serum-free DMEM), was mixed with 1 μl of Lipofectamine 2000 (diluted in qsp 50 μl of serum-free DMEM). The mixtures were incublated at room temperature for 20 min. and then added to freshly trypsinised ES cell culture, in suspension in 400 μl of complete medium (with serum and LIF) without antibiotics. Medium was changed on day 2 and cells were re-transfected on day 3. Cells were harvested for RNA preparation or fixed on day 5, 10 min. at 4°C in 2% formaldehyde/ 0.2% glutaraldehyde in PBS and stained with the Alkaline Phosphatase kit (Sigma-Aldrich, 86R-1KT) according to the manufacturer.
Primer sequences used for esiRNA synthesis are available on request.
